CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics Inc. (NASDAQ:MCRB), a leading microbiome therapeutics platform company, announced today that management will host a conference call and live audio webcast on Tuesday, Nov. 10, 2015, at 10 a.m. EST to discuss financial results for the third quarter ended Sept. 30, 2015, and to provide a business update.
To access the conference call, please dial 888-834-1266 (domestic) or 440-996-5713 (international) and reference the conference ID number 65547781. To join the live webcast please visit the “Investors and Media” section of the Seres website at www.serestherapeutics.com.
A webcast replay will be available on the Seres website beginning approximately two hours after the event and will be archived for 14 days.
About Seres Therapeutics
Seres Therapeutics Inc. is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome.